Cargando…
Single-dose Intranasal Delivery with DEF201 (Adenovirus Vectored Mouse Interferon-α) Protects Against Phlebovirus and Sars Coronavirus Challenge
Autores principales: | Gowen, Brian, Barnard, Dale, Wong, Min-Hui, Larson, Deanna, Wu, Josh, Ennis, Jane, Morrey, John, Turner, Jeffery |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133965/ http://dx.doi.org/10.1016/j.antiviral.2010.02.376 |
Ejemplares similares
-
Single-Dose Intranasal Treatment with DEF201 (Adenovirus Vectored Consensus Interferon) Prevents Lethal Disease Due to Rift Valley Fever Virus Challenge
por: Gowen, Brian B., et al.
Publicado: (2014) -
Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model
por: Kumaki, Yohichi, et al.
Publicado: (2011) -
Therapy and Long-Term Prophylaxis of Vaccinia Virus Respiratory Infections in Mice with an Adenovirus-Vectored Interferon Alpha (mDEF201)
por: Smee, Donald F., et al.
Publicado: (2011) -
Effects of Nasal or Pulmonary Delivered Treatments with an Adenovirus Vectored Interferon (mDEF201) on Respiratory and Systemic Infections in Mice Caused by Cowpox and Vaccinia Viruses
por: Smee, Donald F., et al.
Publicado: (2013) -
Pneumopathies graves liées au COVID-19 : facteurs prédictifs de mortalité après traitement par tocilizumab
por: Kadiane-Oussou, N., et al.
Publicado: (2020)